Outsourcing

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

Articles

2005 has been a good year for the contract services industry, and 2006 promises to be nearly as successful, according to the 2005 PharmSource–Pharmaceutical Technology outsourcing survey. But as pharmaceutical outsourcing activity grows, companies are looking for more sophisticated ways to manage and control their contract services expenditures.

Good Times and Expanding Horizons in Pharmaceutical Manufacturing

Singapore is competing aggressively with India and China for a piece of the Asian sourcing business.

Singapore Fling

The Chapter 11 bankruptcy filing of aaiPharma (Wilmington, NC, www.aaipharma.com), parent of AAI Development Services, was the culmination of an agonizing year-long odyssey. It also was a first step in restoring one of the best-known brands in the CRO industry.

Seeking a Fresh Start

Major pharmaceutical companies are focusing more than ever on the prices CROs are charging for their services.

Price Matters

Achieving the promised benefits of offshore sourcing to India and China is more complicated than it seems.

Orient Express

After a five-year downturn, cautious optimism is taking hold among API manufacturers.

Optimism Taking Over in Pharmaceutical Chemicals

Too many players and threats to the main customer base challenge European dose manufacturers.

Contract Manufacturers Getting Squeezed

Patheon is betting the whole is worth more than the sum of the parts in its acquisition of Puerto Rico contract manufacturer Mova.

Patheon Places Big Bet with Mova Acquisition

The blockage in the new product pipeline may be breaking. CROs report increased demand for late-stage development services in their latest round of earnings reports.

Robust CRO Market Is Driving New Merger and Acquisition Activity

What should pharmaceutical companies make of recent corporate developments at several high-profile service providers?

Outsourcing Outlook